Training Devices & Patient Education Play A Crucial Role in The Self-Injection Drug Delivery Market
The biopharmaceutical industry has experienced incredible exponential growth in recent decades. Annual revenues have increased from US$4.4 billion (£3.4 billion) in 1990 to $275 billion (£213 billion) in 2018 (a… Read More »
Noble and Aptar Pharma Launch AdhereIT®, a Connected Medical Device Solution for Disease Management, Adherence and Onboarding Patients
Crystal Lake, Illinois and Orlando, Florida (October 5, 2020) — Noble and Aptar Pharma are pleased to announce the launch of AdhereIT® — a connected, intuitive and user-friendly onboarding solution… Read More »
AdhereIT 360 Base Demonstration Video
AdhereIT 360 Base Demonstration Video:
Supporting Improved Patient Onboarding and Adherence With Training Solutions
With more biologics and drug delivery device options entering the market in recent years, pharma companies can decide whether it would be easier for patients to self-inject with an autoinjector… Read More »
The Importance of Training and Onboarding for Intranasal Rescue Therapies
Nasal drug repurposing has seen a real resurgence recently, driven by several factors. From an economic perspective, partners benefit from reduced development costs, intellectual property (IP) creation, increased market share… Read More »
Enhancing the Patient Experience for Self-Injection Systems Through Demonstration Devices
Diagnoses of chronic illnesses such as rheumatoid arthritis (RA), Crohn’s disease and osteoporosis are expected to skyrocket in the coming decade, resulting in growing use of patient-centric drug delivery devices… Read More »